Followers | 439 |
Posts | 41282 |
Boards Moderated | 0 |
Alias Born | 10/07/2010 |
Monday, May 11, 2020 11:39:20 AM
Same thing said of Costello’s other play and people were burnt.
How many shares do you think they sold “pre-IPO” on Hempstract?
They would make a few bucks if it were even legal to be selling those shares.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155322287
PRE IPO OPPORTUNITY Convertible Shares 1 for 1 (no dilution) Convertible Common Stock Shares - RESTRICTED Par Value - 0.10 cents per share (PPS - Price Per Share) Lockup- Restriction Period - 6 Months from Date of Issuance Legal opinion required for registration Share certificate transfer conducted by transfer agent. Executed and signed participatory agreement required. Stock Purchase Agreement (SPA) required 15
SHARE BLOCKS AVAILABLE 50,000 shares - 5K USD 100,000 shares - 10K USD 150,000 shares - 15K USD 250,000 shares - 25K USD 500,000 shares - 50K USD 750,000 shares - 75K USD 1,000,000 shares - 100K USD - Warrant Included 1,500,000 shares - 150K USD - Warrant Included 2,500,000 shares - 250K USD - Warrant Included
* Participatory agreement, payment, and SPA required for all share block purchases. 16
SHAREHOLDER COMMUNICATION Accesswire News for Press Releases (PR) Company Twitter - twitter.com/hempstractlabs Company Instagram - instagram.com/hempstractlabs Facebook Account - facebook.com/groups/hempstractlabs Website - www.hempstractlabs.com Facebook + Twitter Fan Clubs (These social media fan sites are not managed or operated by Hempstract or its management.)
17
CONTACTS + BACKGROUND Justin Costello | Chief Executive Officer jcostello@hempstractlabs.com Todd T. Talley | President ttalley@hempstractlabs.com Greg Haynes | Chief Operations Officer ghaynes@hempstractlabs.com Richard Hawkins | Chief Financial Officer rhawkins@hempstractlabs.com 18
HEMPSTRACTLABS.COM 19
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM